• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association between genotype and phenotype in uromodulin-associated kidney disease.尿调素相关肾病的基因型与表型相关性。
Clin J Am Soc Nephrol. 2013 Aug;8(8):1349-57. doi: 10.2215/CJN.11151012. Epub 2013 May 30.
2
A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.常染色体显性遗传性肾小管间质性肾病中的一种新型尿调蛋白突变:基于家系的研究和文献复习。
Ren Fail. 2018 Nov;40(1):146-151. doi: 10.1080/0886022X.2018.1450757.
3
Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.一个导致晚发性常染色体显性遗传性终末期肾衰竭的 UMOD 框内缺失突变的特征分析。
Clin J Am Soc Nephrol. 2011 Dec;6(12):2766-74. doi: 10.2215/CJN.06820711. Epub 2011 Oct 27.
4
Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.常染色体显性遗传性肾小管间质性肾病:ADTKD-UMOD 和 ADTKD-MUC1 患者的临床表现。
Am J Kidney Dis. 2018 Sep;72(3):411-418. doi: 10.1053/j.ajkd.2018.03.019. Epub 2018 May 18.
5
Novel UMOD mutations in familial juvenile hyperuricemic nephropathy lead to abnormal uromodulin intracellular trafficking.家族性少年型高尿酸血症肾病中的新型 UMOD 突变导致尿调蛋白的异常细胞内转运。
Gene. 2013 Dec 1;531(2):363-9. doi: 10.1016/j.gene.2013.08.041. Epub 2013 Aug 27.
6
Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.尿调蛋白突变类型和等位基因状态影响小鼠尿调蛋白相关性肾病的发病和严重程度。
Hum Mol Genet. 2013 Oct 15;22(20):4148-63. doi: 10.1093/hmg/ddt263. Epub 2013 Jun 6.
7
No amelioration of uromodulin maturation and trafficking defect by sodium 4-phenylbutyrate in vivo: studies in mouse models of uromodulin-associated kidney disease.体内应用苯丁酸钠不能改善尿调素成熟和转运缺陷:尿调素相关肾病小鼠模型的研究。
J Biol Chem. 2014 Apr 11;289(15):10715-10726. doi: 10.1074/jbc.M113.537035. Epub 2014 Feb 24.
8
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.由 UMOD 基因突变引起的遗传性肾小管间质性肾炎的表型和结局。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2429-38. doi: 10.2215/CJN.01220211. Epub 2011 Aug 25.
9
A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease.尿调节蛋白疾病中的一种新型突变模式:2型常染色体显性遗传性髓质囊性肾病、家族性青少年高尿酸血症肾病和常染色体显性遗传性肾小球囊性肾病。
Am J Kidney Dis. 2005 Jul;46(1):52-7. doi: 10.1053/j.ajkd.2005.04.003.
10
Standardized, systemic phenotypic analysis of Umod(C93F) and Umod(A227T) mutant mice.Umod(C93F)和Umod(A227T)突变小鼠的标准化、系统性表型分析。
PLoS One. 2013 Oct 24;8(10):e78337. doi: 10.1371/journal.pone.0078337. eCollection 2013.

引用本文的文献

1
Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression.量化影响常染色体显性遗传性肾小管间质性肾病进展速率和严重程度的临床及遗传因素。
J Pharmacokinet Pharmacodyn. 2025 Jul 24;52(4):41. doi: 10.1007/s10928-025-09989-0.
2
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.通过靶向TMED货物受体可挽救尿调节蛋白转运的破坏。
J Clin Invest. 2024 Dec 16;134(24):e180347. doi: 10.1172/JCI180347.
3
Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.等位基因对尿调蛋白聚集体的影响导致常染色体显性遗传性肾小管间质性肾病。
EMBO Mol Med. 2023 Dec 7;15(12):e18242. doi: 10.15252/emmm.202318242. Epub 2023 Oct 26.
4
A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases.遗传修饰物在肾小管间质性肾脏疾病中的作用。
Genes (Basel). 2023 Aug 3;14(8):1582. doi: 10.3390/genes14081582.
5
Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management.慢性肾脏病的遗传易感性:联系、风险与管理
Int J Nephrol Renovasc Dis. 2023 Jan 5;16:1-15. doi: 10.2147/IJNRD.S363041. eCollection 2023.
6
ADTKD- in a girl with a mutation: A case report.伴有一种突变的女孩的成人多囊肾病:一例报告。
Front Med (Lausanne). 2022 Dec 20;9:1077655. doi: 10.3389/fmed.2022.1077655. eCollection 2022.
7
A founder variant is a common cause of hereditary nephropathy in the British population.一个种系变异是英国家族性肾病的常见病因。
J Med Genet. 2023 Apr;60(4):397-405. doi: 10.1136/jmg-2022-108704. Epub 2022 Aug 29.
8
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease.常染色体显性遗传性肾小管间质性肾病的临床与遗传学特征
Nephrol Dial Transplant. 2023 Feb 13;38(2):271-282. doi: 10.1093/ndt/gfab268.
9
Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.常染色体显性遗传性肾小管间质性肾病:不仅仅是 HNF1β。
Pediatr Nephrol. 2022 May;37(5):933-946. doi: 10.1007/s00467-021-05118-4. Epub 2021 May 22.
10
Familial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation.男孩幼年早发型家族性高尿酸血症伴新基因突变
CEN Case Rep. 2021 Aug;10(3):426-430. doi: 10.1007/s13730-020-00566-7. Epub 2021 Feb 22.

本文引用的文献

1
Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasome.尿调素通过 NLRP3 炎性小体触发 IL-1β 依赖性先天免疫。
J Am Soc Nephrol. 2012 Nov;23(11):1783-9. doi: 10.1681/ASN.2012040338. Epub 2012 Sep 20.
2
Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.尿调节蛋白相关肾病的流行病学——一项全国性调查结果
Nephron Extra. 2012 Jan;2(1):147-58. doi: 10.1159/000339102. Epub 2012 Jun 1.
3
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.由 UMOD 基因突变引起的遗传性肾小管间质性肾炎的表型和结局。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2429-38. doi: 10.2215/CJN.01220211. Epub 2011 Aug 25.
4
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease.尿调蛋白(Tamm-Horsfall 蛋白)的再发现:从肾小管间质性肾病到慢性肾脏病。
Kidney Int. 2011 Aug;80(4):338-47. doi: 10.1038/ki.2011.134. Epub 2011 Jun 8.
5
Uromodulin-associated kidney disease.尿调素相关肾脏疾病。
Nephron Clin Pract. 2011;118(1):c31-6. doi: 10.1159/000320889. Epub 2010 Nov 11.
6
A case of familial juvenile hyperuricemic nephropathy with novel uromodulin gene mutation, a novel heterozygous missense mutation in Korea.韩国一例家族性青少年高尿酸血症性肾病伴新型尿调素基因突变,一种新型杂合错义突变。
J Korean Med Sci. 2010 Nov;25(11):1680-2. doi: 10.3346/jkms.2010.25.11.1680. Epub 2010 Oct 26.
7
Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression.尿调蛋白在肾脏初级纤毛中表达,而 UMOD 突变导致纤毛尿调蛋白表达减少。
Hum Mol Genet. 2010 May 15;19(10):1985-97. doi: 10.1093/hmg/ddq077. Epub 2010 Feb 18.
8
Childhood course of renal insufficiency in a family with a uromodulin gene mutation.家族性尿调蛋白基因突变致儿童肾功能不全的病程。
Pediatr Nephrol. 2010 Jul;25(7):1355-60. doi: 10.1007/s00467-009-1436-y. Epub 2010 Feb 12.
9
Uromodulin levels associate with a common UMOD variant and risk for incident CKD.尿调蛋白水平与 UMOD 常见变异体和 CKD 发病风险相关。
J Am Soc Nephrol. 2010 Feb;21(2):337-44. doi: 10.1681/ASN.2009070725. Epub 2009 Dec 3.
10
Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.导致家族性青少年高尿酸血症肾病的尿调节蛋白突变会导致蛋白质成熟缺陷并滞留在内质网中。
Hum Mol Genet. 2009 Aug 15;18(16):2963-74. doi: 10.1093/hmg/ddp235. Epub 2009 May 22.

尿调素相关肾病的基因型与表型相关性。

Association between genotype and phenotype in uromodulin-associated kidney disease.

机构信息

Renal Research Institute, 207 East 94th Street, New York, NY 10128, USA.

出版信息

Clin J Am Soc Nephrol. 2013 Aug;8(8):1349-57. doi: 10.2215/CJN.11151012. Epub 2013 May 30.

DOI:10.2215/CJN.11151012
PMID:23723338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3731914/
Abstract

BACKGROUND AND OBJECTIVES

Uromodulin-associated kidney disease (UAKD) is an autosomal dominant disease caused by uromodulin (UMOD) gene mutations. This study explored genotype-phenotype correlations by examining the relationship between the type of UMOD mutation and the age at onset of ESRD.

DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: Extensive bibliographic research was used to ascertain patient-level data of all patients with UAKD published up to October 2011. Data included sex; ages at onset of hyperuricemia, gout, and ESRD; and UMOD genotype. Kaplan-Meier analysis and Cox proportional hazards models fitted with shared gamma frailty terms to adjust for within-family correlations were used to model time to event.

RESULTS

Thirty-one peer-reviewed publications reporting on 202 patients from 74 families with 59 different UMOD mutations were included. Median ages at onset of hyperuricemia, gout, and ESRD were 24, 40, and 56 years, respectively. Men developed gout and ESRD significantly earlier than did women (age at ESRD was 50 years for men and 60 for women; P=0.04, shared frailty model). Median ages at ESRD development were lowest with Cys77Tyr (37.5 years) and highest with Gln316Pro (65.5 years) UMOD mutations. Onset of ESRD was significantly earlier with UMOD mutations located within the epidermal growth factor domains 2 and 3 (range, 45-52 years; P<0.01 and 0.04, respectively) compared with the cysteine-rich domains (range, 60-65 years; by shared frailty model).

CONCLUSIONS

The UMOD genotype is related to the clinical phenotype of UAKD. This finding may assist in counseling of patients.

摘要

背景与目的

尿调蛋白相关肾病(UAKD)是一种常染色体显性遗传病,由尿调蛋白(UMOD)基因突变引起。本研究通过考察 UMOD 突变类型与终末期肾病(ESRD)发病年龄之间的关系,探讨基因型与表型的相关性。

设计、地点、参与者和测量:广泛查阅文献,确定截至 2011 年 10 月发表的所有 UAKD 患者的个体患者数据。数据包括性别;高尿酸血症、痛风和 ESRD 的发病年龄;以及 UMOD 基因型。采用 Kaplan-Meier 分析和 Cox 比例风险模型,拟合共享伽玛残差项以调整家系内相关性,对事件时间进行建模。

结果

共纳入 31 篇同行评议文献,涉及来自 74 个家系的 202 例患者和 59 种不同的 UMOD 突变。高尿酸血症、痛风和 ESRD 的中位发病年龄分别为 24、40 和 56 岁。男性痛风和 ESRD 的发病年龄明显早于女性(男性 ESRD 发病年龄为 50 岁,女性为 60 岁;P=0.04,共享残差模型)。UMOD 突变 Cys77Tyr(37.5 岁)和 Gln316Pro(65.5 岁)的 ESRD 发病中位年龄最低,而 UMOD 突变位于表皮生长因子域 2 和 3(范围 45-52 岁;P<0.01 和 0.04)的 ESRD 发病年龄明显早于富含半胱氨酸的结构域(范围 60-65 岁;共享残差模型)。

结论

UMOD 基因型与 UAKD 的临床表型相关。这一发现可能有助于对患者进行咨询。